Our way of working is based on a comprehensive approach to the patient to understand the problem or disease of each patient from multiple points of view. In this way, professionals from different specialties contribute our knowledge to solve each case in the most effective way possible. This takes into account not only the aspects strictly related to the disease itself but also the expectations and the particular situation of each patient.
Our multidisciplinary team is made up of multiple specialists dedicated to both Gynecological Cancer and other Gynecological Pathologies.
Our Medical Team in Valencia, Spain
Our doctors have been recognized with prestigious awards and are endorsed by such important medical institutions and societies, nationally throughout Spain and internationally.
A first-class medical team..
Dr. Lucas Minig
I am a Gynecologist Oncologist Specialist in the surgical treatment of ovarian cancer with peritoneal carcinomatosis, endometrial cancer, and cervical cancer. Specialist in minimally invasive laparoscopic surgery for gynecological cancer.
Dr. Cristina Zorrero Martínez
Dr. Cristina Zorrero is an experienced gynecologist with more than 15 years dedicated to the study and treatment of patients with gynecological cancer and radical surgery for pelvic cancer.
She completed her residency program in Gynecology and Obstetrics at the Clinical Hospital of Valencia between 2002 and 2006. After that, she developed in the field of gynecological cancer surgery at the IVO Foundation in Valencia, Spain until 2019. During that period she was able to complete two training stays at the prestigious “The Royal Hospital for Women Foundation, Australia” and at the European Institute of Oncology, Milan Italy”. There she acquired extensive training in the field of complex surgery for gynecological cancer.
She is currently the author of numerous scientific articles and book chapters, she is a professor of gynecology at the CEU Cardenal Herrera University in Valencia, Spain, and is intensely dedicated both to the diagnosis and treatment of women with gynecological cancer and to those women who need a pelvic surgery for benign and complex gynecological pathology.
Dr. David Dávila Dorta
Dr. Dávila is an accredited and significant surgeon with extensive and expert experience for more than 40 years in General and Digestive Surgery. He has been Head of the Esophageal-Gastric Surgery, Morbid Obesity, and Complex Abdominal Wall Surgery Unit at the General University Hospital of Valencia and, simultaneously, with a long journey in personalized patient care in his private practice. He is a reference in surgery both in Spain and internationally, as well as the author of numerous scientific articles that have described surgical techniques that are currently carried out in various parts of the planet.
Dr. Miguel Ramírez Backhaus
Dr. Ramírez Backhaus is a prestigious specialist in Urology. Graduated from the University of Navarra and Doctor “cum laude” from the University of Valencia. Trained in the Urology Service of Hospital La Fe, he completed his training by becoming a Fellow in laparoscopic surgery at the Urology Service of Leipzig, Germany. He returned to Hospital la Fe and later moved to Hospital de la Ribera, where he pioneered the application of pelvic laparoscopy.
He is currently clinical head at the IVO Foundation, in Valencia, Spain, collaborates in several multi-center international scientific research projects, is a member of the Editorial Committee of the journal “Archivos Españoles de Urología”, “Actas urológicas”, “BMC urology” and “ International Journal of Urology”. He has carried out different international stays in different urological centers of reference in urologic-oncology, to highlight MSKCC in New York. In addition, he has completed three postgraduate master’s degrees, among which the CNIO’s master’s degree in Molecular Oncology stands out. Currently, he is also co-director of Urosalud.
Dr. José Domínguez Escrig
Dr. Domínguez is a renowned specialist in Urology. He has more than 20 years of experience in the profession. Graduated from the University of Valencia in 1994, he completed his specialized training in Urology in the United Kingdom (MRCS and FRCS Urology 2009), combining his healthcare work with teaching and developing his research activity at the prestigious University of Newcastle and the «Northern Institute for Cancer Research”, receiving the title of Doctor of Medicine from said University in 2006.
He has participated in numerous international conferences and congresses and is the author of multiple scientific articles on the specialty. Also, he collaborates as a reviewer and corrector of prestigious national and international scientific journals.
He is an associate member of the European clinical guideline panel on non-muscle-infiltrating urothelial carcinoma of the bladder and upper urinary tract. He is also the Spanish delegate to the European Council of Urology (E.B.U.) and a member of the European examining committee.
He is currently a urologist at the I.V.O. and co-director of Urosalud at the Casa de Salud Hospital in Valencia. Combining care activity and translational research in bladder and prostate cancer.
Anesthesia and Intensive Care Unit:
Dr. Juan Carlos Valía Vera
Dr. Juan Carlos Valía completed his residency in Anesthesia and Resuscitation at the General Hospital of Valencia, Spain, from 1990 to 1993. He developed the first steps of the specialty in clinical anesthesia and chronic pain. Subsequently, his field of clinical-scientific action was oriented towards critical patients in the Intensive Care Unit, a fact that led him to carry out numerous investigations that have discovered numerous diagnostic and therapeutic techniques that, after being published in international scientific journals, are currently carried out in multiple hospitals around the world.
He is a tireless and passionate professional who directed the intensive care unit of the General Hospital of Valencia between 2006 and 2017. Since 2017 he has been the Head of the Anesthesia and Resuscitation Service and the Intensive Care Unit of the prestigious IMED Hospital, in Valencia, Spain.
Dr. Salvador Garcerá Juan
Dr. Salvador Garcerá has been dedicated full-time to cancer patients for more than 20 years. He is passionate about his profession with great commitment and empathy with his cancer patients. Dr. Garcerá completed his medical residency program in Medical Oncology at La Fe University Hospital in Valencia, Spain between the years 1994 to 1997. After that, he worked in the Medical Oncology Service of the Hospital de San Juan de Alicante, Hospital General de Elda, and Hospital Dr. Peset de Valencia.
Most of his clinical, teaching, and research experience was developed at the Hospital de La Ribera in Alzira, Valencia from 1999 to 2015. During his career, he has participated and continues to participate in numerous clinical trials with the aim of extending cancer survival and improving the quality of life of patients. Currently, he works as Head of the Medical Oncology Service at the Manises Hospital, Valencia, Spain, a job that he combines with private medicine. He travels the world to acquire the best training and updating and make available to patients the most effective cancer treatments for each patient.
Medical oncology – Nutrition of the cancer patient:
Dr. Martín Oré Arce
Dr. Martin Oré is a medical oncologist with experience in the treatment of different types of tumors, among his main areas of interest are gynecological cancer, genitourinary tumors, and lung cancer. He completed his residency program in Medical Oncology at the General University Hospital of Elche-Alicante between 2011 and 2016. After that, he completed a 2-year training stay at the Gynecological Gynecology Clinical Area of the Valencian Institute of Oncology, forming part of a multidisciplinary team with internationally recognized professionals. This allowed him to acquire extensive training in the comprehensive management of gynecological tumors. Dr. Oré is the author of several scientific articles, is a speaker at scientific meetings, and has presented different scientific papers at national and international conferences.
Within the comprehensive treatment of tumors, adequate nutrition and the incorporation of healthy lifestyle habits on a daily basis are associated with better therapeutic results and better tolerance of the side effects of treatments. For this reason, Dr. Oré has been trained in the field of oncological nutrition, obtaining the title of “Experto en Nutrición y Salud en Oncología” or “Expert in Nutrition and Health in Oncology” issued by the University of Barcelona. In addition, he is part of the Exercise and Cancer working group of the Spanish Society of Medical Oncology SEOM.
Dr Pablo Soler Catalán
Dr. Pablo Soler Catalán is a specialist in Radiation Oncology. Graduated from the University of Navarra (2007) and Doctor cum laude from the University of Valencia (2016). Trained in the Radiotherapy Oncology Service at the IVO Foundation, in Valencia (2008-2012). Later he moved to IMED Elche where, as Head of Service, he launched and developed a cutting-edge Radiotherapy Oncology Service, including the High Rate Brachytherapy Unit (HDR), being an option of special interest in the approach to tumors of breast, gynecological, and prostate.
Since 2017, he has been the Head of Hospital IMED Valencia, with state-of-the-art technological equipment that allows the performance of all the most advanced radiotherapy techniques in the world, especially relevant in gynecological and urological tumors.
He holds the International Master’s Degree in Radiation Oncology from the Francisco de Vitoria University. He is a member of the SEOR (Spanish Society of Radiation Oncology) and GORVAMUR (Radiation Oncology Group of the Valencian Community and Murcia). He has participated in numerous presentations and congresses, publishing articles of interest in his field, in impact magazines.
Comprehensive Patient Approach
The comprehensive approach is essential to understand the problem of each patient from multiple points of view. In this way, professionals from different specialties contribute their knowledge to solve each case in the most effective way possible.
The multidisciplinary team includes gynecological oncologists, general and thoracic surgeons, anesthesiologists, instrumentalists, medical and radiotherapist oncologists, radiologists, specialized pathologists, and pisco-oncologists.
Development and application of highly complex surgical and medical treatments
The development and application of highly complex surgical and medical treatments are one of the fundamental bases for offering the most effective therapies available.
These include both minimally invasive laparoscopic and robotic surgery, as well as multidisciplinary surgery for advanced ovarian cancer with peritoneal carcinomatosis. In addition, medical treatments include state-of-the-art molecular drugs and immunotherapy for the treatment of gynecological cancer.
Personalized attention and excellence
Personalization in the care of each patient’s problems leads to better care and better therapeutic results. For this, it is essential to work in multidisciplinary teams without ever losing the objective: the patient.
In addition, it is important to offer the latest advances, both diagnostic and therapeutic. That is why teaching, research, and continuous updating are so important.
Warm and human treatment inpatient care.
The close and human treatment is the most important point in the care of my patients since it can improve the result of any treatment, however, complex it may be. Without that, it would be impossible to practice medicine.
Patients, more than a professionally trained doctor, also need a warm look and a close and human treatment.
Research and innovation
Research and innovation are the basis for the advancement of medicine in each specific field. Thus, we carry out multiple clinical and molecular studies related to gynecological cancer and highly complex gynecological surgery published in international scientific journals.
In addition, I am the author of numerous international book chapters:
- Aletti G, Minig L, Zanagnolo V (2018). “Radical pelvic and retroperitoneal Ovarian Cancer Surgery”. En “Principles of Gynecologic Oncology Surgery”. Ed. ELSEVIER, ISBN: 978-0-323-42878.
- Minig L, Bover I, Zorrero C, Poveda A. (2017) “Diagnosis, staging and early diagnosis of ovarian cancer”. In “Practical book of ovarian cancer”. Ed. Permanyer. ISBN: 978-84-17221-08-9.
- Martínez Castro P, Zorrero C, Minig L. (2017) “Surgery of ovarian cancer: concepts.” In “Practical book of ovarian cancer”. Ed. Permanyer. ISBN: 978-84-17221-08-9.
- Minig L, Trimble EL, Colombo N (2017) Optimal Treatment for Women with Ovarian Cancer. In: Schwab M (Ed.) Encyclopedia of Cancer, 4th edition. Springer-Verlag Berlin Heidelberg, Vol. 4, pp. 3236-3242.
- Minig L, Romero I. “Other therapies for endometrial cancer”. On the “Text book of gynecological Oncology”. European Society of Gynecological Oncology (ESGO) 2016.
- Minig L, Randal T. “Unanswered questions in gynecology oncology”. On the “Text book of gynecological Oncology”. European Society of Gynecological Oncology (ESGO) 2016.
- Colombo N, Minig L. “Treatment of early stage ovarian cancer”. On the “Text book of gynecological Oncology”. European Society of Gynecological Oncology (ESGO) 2016.
- Minig L, Domingo S. Vulvar and Vaginal Cancer. On the text book “Management of gynecologic tumors”. I. Zapardiel (Eds) Published by: Pierre Fabre Ibérica. Madrid Spain, 2016. ISBN: 978-84-608-5602-3
- Minig L, Pereira D. Treatment of early stage ovarian cancer. On the text book: 100 Key Questions in Ovarian Cancer. Poveda Velazco A (Eds). Published by Permanyer. Mallorca, 310 – 08037 Barcelona (Catalonia), Spain.
- Minig L, Zorrero C, Martinez Castro P. Robotic Surgery in women with ovarian cancer. On the text book: Robotic in Gynecology. Gorostidi Pulgar M (Eds). Published by OMICS Group eBooks. 731 Gull Ave, Foster City, CA 94404, USA.* Available from: http://www.esciencecentral.org/ebooks/robotics-in-gynecology/robotic-surgery-in-women-with-ovarian-cancer.php
- Colombo N, Minig L, Burger R. Maintenance Therapy for First-Line Treatment of Ovarian Cancer: Is This the Strategy for the Future? On the text book: J.A. Ledermann et al. (eds.), Controversies in the Management of Gynecological Cancers, DOI 10.1007/978-0-85729-910-9_15, © Springer-Verlag London 2014.
- Minig L, Patrono MG, Alvarez Gallego R, Valero de Bernabé J and Diaz-Padilla I (2013). Surgical Treatment of Ovarian Cancer, Ovarian Cancer – A Clinical and Translational Update, Dr. Ivan Diaz-Padilla (Ed.), ISBN: 978-953-51-1030-9, InTech, DOI: 10.5772/53972. Available from: http://www.intechopen.com/books/ovarian-cancer-a-clinical-and-translational-update/surgical-treatment-of-ovarian-cancer
- Minig L, Trimble EL. “Unanswered questions in gynecology oncology”. On the “Text book of gynecological Oncology”. European Society of Gynecological Oncology (ESGO) 2010.
- Minig L, Colombo N. “Treatment of early stage ovarian cancer”. On the “Text book of gynecological Oncology”. European Society of Gynecological Oncology (ESGO) 2010.
- Minig L. “Biología molecular y Genética”. on “Libro de ginecología del hospital italiano de Buenos Aires”. Editor. Dr Roberto Testa. 2010
- Martinotti R, Minig L «Premature Rupture of Membranes». PROAGO. Program of Update on Gynecology and Obstetrics. System of continuing and distance medical education. Eight cycle. 2004, Module 3. Pages 77-108.
- Martinotti R, Minig L. “Prenatal use of corticosteroids” PRONEO. Program of Update on Neonatology. System of continuing and distance medical education. Fifth cycle. 2004, Module 1. Pages 45-69.
- Sebastiani M, Minig L. Multiple pregnancy. Part I: Prenatal care PRONEO. Program of Update on Neonatology, 2006, Seven cycle, Module 1: Page 13-33 Editorial Médica Panamericana.